MAZE Sale Disclosure
Coloma Jason V · SEC Form 4 · Filed Nov 4, 2026
Sale
Calculated transaction value
$10.39K
Coloma Jason V Chief Executive Officer
MAZE
Maze Therapeutics
MAZE
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
MAZE daily price context
Close on/before transaction
$30.37
Nov 2, 2026
First close after public filing
$32.53
Nov 5, 2026
Return after filing · so far
+5.1%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 336 shares @ $30.91
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001676170-26-000026
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$1.04M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Maze Therapeutics, Inc. MAZE | Sale | Nov 2, 2026 | $799.41K |
| Maze Therapeutics, Inc. MAZE Current | Sale | Nov 2, 2026 | $10.39K |
| Maze Therapeutics, Inc. MAZE | Sale | Nov 2, 2026 | $67.99K |
| Maze Therapeutics, Inc. MAZE | Sale | Nov 2, 2026 | $165.98K |